Attovia Therapeutics Statistics
NASDAQ: ATTOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
16.00-0.425 (-2.59%)
Market open · Delayed 15 min · as of Oct 8, 1:13 PM ET
Attovia Therapeutics by the numbers
Attovia Therapeutics has a market capitalization of $730.2 million based on 45.65M shares outstanding. With trailing EPS of $-2.74, Attovia Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.5% below its 50-day average and 22.5% below its 200-day average.
Average daily trading volume is 458.24K shares, or about $7.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ATTO valuation vs. peer median
| Metric | ATTO | Peer median | Difference |
|---|---|---|---|
| Market cap | $730.19M | $712.04M | +3% |
| Avg. volume | 458.24K | 1.26M | -64% |
Peer median across 8 companies: DNA, CADL, SLDB, FDMT, AURA, PRME, SANA, PROK.
Valuation
- Market cap
- $730.19M
- EPS (TTM)
- $-2.74
- Shares outstanding
- 45.65M
Price and trading
- Previous close
- 16.42
- Open
- 16.27
- Day range
- 15.48 – 16.38
- 52-week range
- 15.48 – 28.00
- Beta
- —
- Volume
- 175.97K
- Average volume
- 458.24K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 11, 2026
Additional statistics
- Market Cap
- 730.19M
- Forward Pe
- -6.72
- Eps
- -2.74
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 28.00
- Week52 Low
- 15.48
- Avg Volume
- 458.24K
- Shares Outstanding
- 45.65M
- Ma50
- 20.64
- Ma200
- 20.64
- Earnings Date
- Nov 11, 2026
- Pct From52w High
- -42.87%
- Pct From52w Low
- 3.33%